Lyophilized Powder This product is freeze dried. All water molecules have been removed.
Antigen Incl. This antibody is shipped with its antigen FREE of charge!
- Peptide (C)KEAS RTR*SG GPKGS K, corresponding to amino acid residues 243-257 of rat B1R with replacement of cysteine 250 (C250) with serine (*S) (Accession P97583). 3rd intracellular loop.

-
Western blot analysis of rat brain (lanes 1 and 3) and heart (lanes 2 and 4) lysates:1. Anti-B1 Bradykinin Receptor (BDKRB1) Antibody (#ABR-011), (1:200).
2. Anti-B1 Bradykinin Receptor (BDKRB1) Antibody, preincubated with the negative control antigen.
-
Expression of B1 bradykinin receptor in rat CNSImmunohistochemical staining of frozen rat brain section (A & B) and cerebellum (C) using Anti-B1 Bradykinin Receptor (BDKRB1) Antibody (#ABR-011), (1:50). BKR1 is expressed in neuronal cells of the amygdala (A) and hippocampus (CA1) (B) as well as in the axons of Purkinje cells in the cerebellum (arrowheads on C). Hoechst 33342 is used as the counterstain.Mouse spinal cord (1:200), (Dutra, R.C. et al. (2013) Neurobiol. Dis. 54, 82.).
- Rat trigeminal neuron primary cultures (Kawaguchi, A. et al. (2015) Front. Cell. Neurosci. 9, 229.).
- 1. Walker, K. et al. (1995) Neurochem. Int. 26, 1.
- 2. Böckmann, S. and Paegelow, I. (2000) J. Leukoc. Biol. 68, 587.
- 3. Hess, J.F. et al. (2004) J. Pharmacol. Exp. Ther. 310, 488.
-
Kinins are small peptides rapidly produced following tissue injury that serve as important modulators of inflammation and pain. In the periphery, the actions of kinins include vasodilatation, increased vascular permeability, stimulation of immune cells, and induction of pain. Kinins in the central nervous system (CNS) appear to initiate a similar cascade of events leading to neural tissue damage as well as long lasting disturbances affecting blood-brain barrier function.1
Kinins such as Bradykinin (BK), Lys-BK, desArg9-BK, and Lys-desArg9-BK exert their action via two distinct receptors: the B1 Bradykinin receptor (BKRB1) and the B2 Bradykinin receptor (BKRB2). The desArg9-BK and Lys-desArg9-BK peptides activate BKRB1 while BK and Lys-BK operate by activating BKRB2.2 Both BKRB1 and BKRB2 are members of the seven-transmembrane domain, G protein-coupled receptor (GPCR) superfamily and share a common structure of seven putative transmembrane domains, an extracellular amino terminus, and a cytoplasmic carboxyl terminus.
Expression of BKRB1is inducible upon various types of tissue injury and by inflammatory mediators such as bacterial lipopolysaccharide (LPS) and cytokines. BKRB1 was long considered not to be expressed in healthy tissues. However, recent work has demonstrated a low level of expression of BKRB1 in the CNS of rodent and primates. In contrast, BKRB2 is constitutively expressed on various cell types.3 BKRB1 represents a potential therapeutic target for treatment of inflammatory disorders and cardiovascular diseases.

Expression of B1 bradykinin receptor in rat TG neurons.Immunocytochemical staining of rat primary trigeminal ganglion (TG) neurons using Anti-B1 Bradykinin Receptor (BDKRB1) Antibody (#ABR-011). Adapted from Kawaguchi, A. et al. (2015) Front. Cell. Neurosci. 9, 229. with permission of Frontiers.
Anti-B1 Bradykinin Receptor (BDKRB1) Antibody (#ABR-011) is a highly specific antibody directed against an epitope of the rat protein. The antibody can be used in western blot, immunohistochemistry, and immunocytochemistry applications. It has been designed to recognize B1R from rat and mouse samples. The antibody may not recognize the receptor from human samples.
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
1) 物素N—羟基丁二酰亚胺酯(biotinyl-N-hydroxy-succinnimideBNHS)制备:
取物素1g混悬于12 mlN,N-二甲基甲酰胺(DMF)加0.6g N-羟基丁二酰亚胺(HOSU)0. 8 g二环基碳二亚胺(DCC)置于密闭容器内室温磁力搅拌作用夜滤滤液经旋转蒸干加10mL乙醚洗涤继加200 ml异丙醇使其重结晶获白色粉末状晶体
BNHS酯键-C=0基团与蛋白质赖氨酸氨基结合使物素标记蛋白含赖氨酸残基越或蛋白质等电点pI 6.0其标记效越BNHS适用于标记抗体及性偏碱性抗原
河南省郑州市所以食品添加剂有限公司 维生素H1价格 [未实名认证] 国产 1*20 435 元/kg
叶酸和生物素都属于B族维生素,
对维持机体的生理功能有重要作用。
现配现用
链接很容易,就用EDC或者CMC等碳二亚胺,是最容易在羧基和氨基之间催化形成酰胺键,反应条件就是0到4度,过夜,用磁力搅拌子温和搅拌,pH<7反应快,不过pH=7或稍微pH>7也关系不大。EDC或者CMC等碳二亚胺催化活性极高,而且一般的蛋白质的分子表面总有Lys,Arg,Asn,Gln,所以游离在分子表面的羧基和氨基总是不少的,参与反应的两种蛋白质用大致10:1的比例混合(哪种蛋白质便宜,哪种蛋白质的物质的量就大些,但是这不是全部原因),反应样品浓度就按照平时使用时的浓度或略微更低浓度(别用储存液的浓度)即可。很容易反应,而且EDC或者CMC等碳二亚胺是零臂连接试剂,用于空间位阻,形成多分子交联可能较小,即使形成了也很容易用分子筛层析按照分子量区分开。
参与反应的两种蛋白质用大致10:1的比例混合(哪种蛋白质便宜,哪种蛋白质的物质的量就大些,但是这不是全部原因),为了避免两种蛋白质之间发生交联成为串联,因为一种蛋白质形成串联的可能性低一些;即使要形成串联的蛋白质串珠,最好也不要是价格高的那种;另外,EDC或者CMC等碳二亚胺催化活性极高,室温下即会催化,所以要在0到4度,过夜,用磁力搅拌子温和搅拌,一方面避免碳二亚胺催化活性太高形成串联的蛋白质串珠,另一方面,保护蛋白质不变性;反应样品浓度就按照平时使用时的浓度或略微更低浓度(别用储存液的浓度)即可,为什么?因为浓度高了更易形成串联的蛋白质串珠结构,浓度低了,没有反应成功,通过分子筛层析还可以分离出来接着连接,如果形成了酰胺键再要专一性切开就没有那么容易了。

